Eburan, Jimm A.
HRN: 13-44-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2023
CEFTRIAXONE 1G (VIAL)
06/25/2023
07/02/2023
IV
2gms
OD
Acute Uncomplicated Pyelonephritis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes